Antifungal prophylaxis for children with cancer or undergoing haematopoietic stem cell transplant

  •   0.35hrs
  •   Public
  •   Version: 1
  •   Review due: September 2025
New

About

This course presents information about antifungal prophylaxis management relevant for children undergoing cancer treatment or haematopoietic stem cell transplant (HSCT).

Modules

Additional Information


This evidence-based education resource was created by Paediatric Integrated Cancer Service (PICS).

If you have any questions or feedback on the module please contact Dr Gabrielle Haeusler on gabrielle.haeusler@petermac.org  

Other paediatric-related learning opportunities include:

Antifungal prophylaxis for children with cancer or undergoing haematopoietic stem cell transplant

What you will achieve

  • Understand the rationale behind antifungal prophylaxis in children with cancer or undergoing haematopoietic stem cell transplant (HSCT)
  • Describe the risk factors for invasive fungal infections (IFI) in paediatric patient groups and when antifungal prophylaxis is recommended
  • Describe the various antifungal agents used for IFI prophylaxis and the associated management
  • Apply the relevant clinical practice guideline

Who is this course for?

This resource is for medical and nursing staff involved in the care of children. It is primarily targeted at junior medical staff who are working in paediatric oncology.

 

Have an enquiry or feedback?

If you have any questions or would like to provide feedback about this page please submit an enquiry below or visit our FAQ page.

 
Submit enquiry